Journal article
Loss-of-function variants in NFIA provide further support that NFIA is a critical gene in 1p32-p31 deletion syndrome: A four patient series
Anya Revah-Politi, Mythily Ganapathi, Louise Bier, Megan T Cho, David B Goldstein, Parisa Hemati, Alejandro Iglesias, Jane Juusola, John Pappas, Slave Petrovski, Ashley L Wilson, Vimla S Aggarwal, Kwame Anyane-Yeboa
AMERICAN JOURNAL OF MEDICAL GENETICS PART A | WILEY | Published : 2017
DOI: 10.1002/ajmg.a.38460
Abstract
Microdeletions of 20q11.2 are rare but have been associated with characteristic clinical findings. A 1.6 Mb minimal critical region has been identified that includes three OMIM genes: GDF5, EPB41L1, and SAMHD. Here we describe a male monozygotic, monochorionic‐diamniotic twin pair with discordant phenotypes, one with multiple findings that overlap with those reported in 20q11.2 deletions, and the other unaffected. Microarray analysis revealed mosaicism for a 363 Kb deletion encompassing GDF5 in the peripheral blood of both twins, which was confirmed by FISH. Subsequent FISH on buccal cells identified the deletion only in the affected twin. The blood FISH findings were interpreted as represen..
View full abstractGrants
Funding Acknowledgements
David B. Goldstein, PhD is a founder of and holds equity in Pairnomix and Praxis, serves as a consultant to AstraZeneca, and has research supported by Janssen, Gilead, Biogen, and UCB. Slave Petrovski, PhD serves on the advisory board and is an equity holder of Pairnomix. Jane Juusola, PhD and Megan T. Cho, MS, CGC are employees of GeneDx laboratories. Other authors have no conflicts of interest to declare.